Literature DB >> 24228088

The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.

Tsuyoshi Saito1.   

Abstract

Synovial sarcoma (SS) tumor cells, which have the chromosomal translocation t(X;18)(p11.2;q11.2), have an inherently greater propensity for epithelial differentiation than other mesenchymal tumors, especially spindle cell sarcomas. This is caused by de-repression of the transcription of E-cadherin by SYT-SSX1 and SYT-SSX2, which dissociate Snail or Slug, respectively, from the E-cadherin promoter. However, a subset of SS with SYT-SSX1 loses E-cadherin expression despite adequate de-repression because of mutations in E-cadherin, resulting in monophasic histology. The ratio of the expression levels of SYT-SSX1 and Snail is also associated with E-cadherin expression: the lower the SYT-SSX1/Snail ratio, the lower the level of E-cadherin expression, and vice versa, thus affecting tumor histology. In addition, Wnt signal activation caused by mutation of β-catenin, APC, or Axin 1 and 2 is associated with monophasic histology. Remodeling of the extracellular matrix is also important. Only cells that survive all of these steps can finally exhibit biphasic histology. On the other hand, the SYT-SSX2 fusion has a weaker de-repression effect on the E-cadherin promoter than does SYT-SSX1, so it is difficult for SYT-SSX2-expressing tumors to achieve sufficient capacity for epithelial differentiation to form glandular structures. This review provides an interesting model for this epithelial differentiation that shows a possible mechanism for the aberrant mesenchymal to epithelial transition of SS and suggests that it might better be considered an epithelial to mesenchymal transition.

Entities:  

Keywords:  E-cadherin; SYT-SSX1; SYT-SSX2; Synovial sarcoma; chromosomal translocation t(X;18)(p11.2;q11.2); epithelial differentiation

Mesh:

Substances:

Year:  2013        PMID: 24228088      PMCID: PMC3816795     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  41 in total

1.  Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma.

Authors:  T Saito; Y Oda; A Sakamoto; S Tamiya; N Kinukawa; K Hayashi; Y Iwamoto; M Tsuneyoshi
Journal:  J Pathol       Date:  2000-11       Impact factor: 7.996

2.  Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma.

Authors:  T Hasegawa; R Yokoyama; Y Matsuno; T Shimoda; S Hirohashi
Journal:  Hum Pathol       Date:  2001-03       Impact factor: 3.466

3.  The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression.

Authors:  A Cano; M A Pérez-Moreno; I Rodrigo; A Locascio; M J Blanco; M G del Barrio; F Portillo; M A Nieto
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

4.  The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.

Authors:  E Batlle; E Sancho; C Francí; D Domínguez; M Monfar; J Baulida; A García De Herreros
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

5.  E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma.

Authors:  Tsuyoshi Saito; Yoshinao Oda; Ken-ichi Kawaguchi; Keishi Sugimachi; Hidetaka Yamamoto; Naomi Tateishi; Kazuhiro Tanaka; Shuichi Matsuda; Yukihide Iwamoto; Marc Ladanyi; Masazumi Tsuneyoshi
Journal:  Oncogene       Date:  2004-11-11       Impact factor: 9.867

6.  Dishevelled-2 silencing reduces androgen-dependent prostate tumor cell proliferation and migration and expression of Wnt-3a and matrix metalloproteinases.

Authors:  Yinhui Yang; Li Jiao; Jianguo Hou; Chuanliang Xu; Linhui Wang; Yongwei Yu; Yun Li; Chun Yang; Xia Wang; Yinghao Sun
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

7.  Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.

Authors:  C R Antonescu; A Kawai; D H Leung; F Lonardo; J M Woodruff; J H Healey; M Ladanyi
Journal:  Diagn Mol Pathol       Date:  2000-03

8.  The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells.

Authors:  Ofelia M Martínez-Estrada; Albert Cullerés; Francesc X Soriano; Hector Peinado; Victoria Bolós; Fernando O Martínez; Manuel Reina; Amparo Cano; Myriam Fabre; Senén Vilaró
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

9.  Gene expression profiling of human sarcomas: insights into sarcoma biology.

Authors:  Kristin Baird; Sean Davis; Cristina R Antonescu; Ursula L Harper; Robert L Walker; Yidong Chen; Arthur A Glatfelter; Paul H Duray; Paul S Meltzer
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

10.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

View more
  12 in total

1.  A primary intravascular synovial sarcoma causing deep-vein thrombosis and pulmonary embolism in a 20-year-old woman.

Authors:  M Schreiner; W Sanad; B M Pfitzner; G Baumann; F Knebel
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

2.  SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.

Authors:  Yusuke Minami; Shinji Kohsaka; Masumi Tsuda; Kazuhiro Yachi; Nobuaki Hatori; Mishie Tanino; Taichi Kimura; Hiroshi Nishihara; Akio Minami; Norimasa Iwasaki; Shinya Tanaka
Journal:  Cancer Sci       Date:  2014-09-03       Impact factor: 6.716

3.  Clinical features in a man with primary synovial sarcoma of the spermatic cord.

Authors:  Gong-Cheng Wang; Xue-Qin Li; Yun-Yan Wang; Zhong-Ying Guo; Pei-Jin Hou
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

4.  Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells.

Authors:  Yan Qi; Ning Wang; Yonglai He; Jun Zhang; Hong Zou; Wenjie Zhang; Wenyi Gu; Yalan Huang; Xiaojuan Lian; Jianming Hu; Jin Zhao; Xiaobin Cui; Lijuan Pang; Feng Li
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

5.  Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization.

Authors:  Bor-Chyuan Su; Giun-Yi Hung; Yun-Chieh Tu; Wei-Chen Yeh; Meng-Chieh Lin; Jyh-Yih Chen
Journal:  Mar Drugs       Date:  2021-02-05       Impact factor: 5.118

Review 6.  The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.

Authors:  Michele Fiore; Andrea Sambri; Paolo Spinnato; Riccardo Zucchini; Claudio Giannini; Emilia Caldari; Maria Giulia Pirini; Massimiliano De Paolis
Journal:  Curr Treat Options Oncol       Date:  2021-10-23

7.  SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling.

Authors:  Yan Qi; Shuang-Shuang Dong; Yong-Lai He; Zi-Han Liu; Ya-Lan Huang; Ning Wang; Zhen Zhang; Zhong Li; Mei Er Tu He Ta Mi Shi; Xiao Feng; Qing Yao; Hong Zou; Jian-Ming Hu; Li-Juan Pang; Feng Li
Journal:  BMC Cancer       Date:  2022-02-12       Impact factor: 4.430

Review 8.  Metabolic landscapes in sarcomas.

Authors:  Richard Miallot; Franck Galland; Virginie Millet; Jean-Yves Blay; Philippe Naquet
Journal:  J Hematol Oncol       Date:  2021-07-22       Impact factor: 17.388

9.  Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip.

Authors:  Yan Qi; Ning Wang; Li-Juan Pang; Hong Zou; Jian-Ming Hu; Jin Zhao; Jun Zhang; Chun-Xia Liu; Wen-Jie Zhang; Xiang-Lin Yuan; Feng Li
Journal:  BMC Med Genomics       Date:  2015-10-27       Impact factor: 3.063

10.  SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.

Authors:  Changliang Peng; Hui Zhao; Yan Song; Wei Chen; Xiaoying Wang; Xiaoli Liu; Cheng Zhang; Jie Zhao; Ji Li; Guanghui Cheng; Dongjin Wu; Chunzheng Gao; Xiuwen Wang
Journal:  J Exp Clin Cancer Res       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.